Adelbert L. Stagg
General Counsel at AEON Biopharma Sub, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert Palmisano | M | 79 |
AEON Biopharma Sub, Inc.
 AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 1 years |
| Peter Reynolds | M | 66 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 1 years |
| Eric Carter | M | 72 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 1 years |
| Shelley Thunen | F | 71 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 1 years |
| Jost Fischer | M | 69 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 7 years |
| Simone Blank | F | 61 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 1 years |
| Richard Taketa | M | 52 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 6 years |
| Darren O Brien | M | 48 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 1 years |
| Chad Oh | M | 66 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 3 years |
| Chris Carr | M | 54 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 5 years |
| Ed Inal | M | - |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Susan A. Brodsky-Thalken | F | 71 |
Artes Medical, Inc.
 Artes Medical, Inc. Financial ConglomeratesFinance Artes Medical, Inc. is a medical technology company. It is focused on developing, manufacturing and commercializing a new category of injectable aesthetic products for the dermatology and plastic surgery markets. Its products include ArteFill which is a non-resorbable aesthetic injectable implant for the correction of facial wrinkles known as smile lines, or nasolabial folds, for commercial sale in the U.S. The company was founded on August 24, 1999 and is headquartered in San Diego, CA. | 7 years |
| Frank M. Fazio | M | 55 |
Artes Medical, Inc.
Artes Medical, Inc. Financial ConglomeratesFinance Artes Medical, Inc. is a medical technology company. It is focused on developing, manufacturing and commercializing a new category of injectable aesthetic products for the dermatology and plastic surgery markets. Its products include ArteFill which is a non-resorbable aesthetic injectable implant for the correction of facial wrinkles known as smile lines, or nasolabial folds, for commercial sale in the U.S. The company was founded on August 24, 1999 and is headquartered in San Diego, CA. | 7 years |
| Brandi Roberts | F | 50 |
Artes Medical, Inc.
Artes Medical, Inc. Financial ConglomeratesFinance Artes Medical, Inc. is a medical technology company. It is focused on developing, manufacturing and commercializing a new category of injectable aesthetic products for the dermatology and plastic surgery markets. Its products include ArteFill which is a non-resorbable aesthetic injectable implant for the correction of facial wrinkles known as smile lines, or nasolabial folds, for commercial sale in the U.S. The company was founded on August 24, 1999 and is headquartered in San Diego, CA. | 1 years |
| Lon E. Otremba | M | 67 |
Artes Medical, Inc.
Artes Medical, Inc. Financial ConglomeratesFinance Artes Medical, Inc. is a medical technology company. It is focused on developing, manufacturing and commercializing a new category of injectable aesthetic products for the dermatology and plastic surgery markets. Its products include ArteFill which is a non-resorbable aesthetic injectable implant for the correction of facial wrinkles known as smile lines, or nasolabial folds, for commercial sale in the U.S. The company was founded on August 24, 1999 and is headquartered in San Diego, CA. | 2 years |
| John Costantino | M | 77 |
Artes Medical, Inc.
Artes Medical, Inc. Financial ConglomeratesFinance Artes Medical, Inc. is a medical technology company. It is focused on developing, manufacturing and commercializing a new category of injectable aesthetic products for the dermatology and plastic surgery markets. Its products include ArteFill which is a non-resorbable aesthetic injectable implant for the correction of facial wrinkles known as smile lines, or nasolabial folds, for commercial sale in the U.S. The company was founded on August 24, 1999 and is headquartered in San Diego, CA. | 7 years |
| Diane S. Goostree | F | 68 |
Artes Medical, Inc.
Artes Medical, Inc. Financial ConglomeratesFinance Artes Medical, Inc. is a medical technology company. It is focused on developing, manufacturing and commercializing a new category of injectable aesthetic products for the dermatology and plastic surgery markets. Its products include ArteFill which is a non-resorbable aesthetic injectable implant for the correction of facial wrinkles known as smile lines, or nasolabial folds, for commercial sale in the U.S. The company was founded on August 24, 1999 and is headquartered in San Diego, CA. | 2 years |
| Stefan Lemperle | M | - |
Artes Medical, Inc.
Artes Medical, Inc. Financial ConglomeratesFinance Artes Medical, Inc. is a medical technology company. It is focused on developing, manufacturing and commercializing a new category of injectable aesthetic products for the dermatology and plastic surgery markets. Its products include ArteFill which is a non-resorbable aesthetic injectable implant for the correction of facial wrinkles known as smile lines, or nasolabial folds, for commercial sale in the U.S. The company was founded on August 24, 1999 and is headquartered in San Diego, CA. | 7 years |
| Gregory J. Kricorian | M | 54 |
Artes Medical, Inc.
Artes Medical, Inc. Financial ConglomeratesFinance Artes Medical, Inc. is a medical technology company. It is focused on developing, manufacturing and commercializing a new category of injectable aesthetic products for the dermatology and plastic surgery markets. Its products include ArteFill which is a non-resorbable aesthetic injectable implant for the correction of facial wrinkles known as smile lines, or nasolabial folds, for commercial sale in the U.S. The company was founded on August 24, 1999 and is headquartered in San Diego, CA. | - |
| Vanessa Lusitano Jacoby | F | - |
Artes Medical, Inc.
Artes Medical, Inc. Financial ConglomeratesFinance Artes Medical, Inc. is a medical technology company. It is focused on developing, manufacturing and commercializing a new category of injectable aesthetic products for the dermatology and plastic surgery markets. Its products include ArteFill which is a non-resorbable aesthetic injectable implant for the correction of facial wrinkles known as smile lines, or nasolabial folds, for commercial sale in the U.S. The company was founded on August 24, 1999 and is headquartered in San Diego, CA. | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 20 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Adelbert L. Stagg
- Personal Network
